Medical guidance rarely arrives as a single bright line, and this update from the American Cancer Society is one more step in a long human effort to decide when to look for a quiet disease before it speaks. The Society now advises men between 50 and 69 to be screened every two years, a rhythm offered to the public through a CBS segment in which a Columbia urologist, Dr. Christopher Anderson, was asked to explain what it means in practice. The reporting itself is spare, offering the headline and the guest but not the full text, so the deeper reasons and the change from earlier advice remain for
ACS Now Advises Men 50 to 69 to Get Prostate Cancer Screened Every Two Years
A clear interval gives patients and doctors a defined starting point.
So what actually changed here? The headline sounds simple.
The American Cancer Society updated its prostate screening guidance, and the headline says men 50 to 69 should be screened every two years. A urologist, Dr. Christopher Anderson of NewYork-Presbyterian/Columbia, went on CBS to explain it.
Before we go further, how much do we really know? The source is a short video description, not the guideline.
Fair. We know the age range, the interval, and who the guest was. That's about it.
Do we know what the old advice was?
No. Without that, we can't say whether this is a big shift or a refinement. Anyone claiming it is one or the other is going beyond the source.
Right. The value of the story right now is the clear window: 50 to 69, every two years.
Is this about the PSA blood test?
The keywords list PSA testing, but the description itself doesn't say. I'd treat it as likely, not confirmed.
And Anderson's actual comments aren't in the text we have, so I won't put words in his mouth.
So what should a reader do?
Find the full guideline, and talk to their own doctor about how it applies to them.
El Pulso
- A revised screening window of ages 50 to 69, every two years, has landed in the public conversation about prostate cancer.
- The source material is thin, offering only a segment description and no transcript, leaving the size of the change unclear.
- Dr. Christopher Anderson of NewYork-Presbyterian/Columbia has been brought on air to translate the guidance for viewers.
- Readers are pressed to find the full guideline text and compare the new interval with prior recommendations.
- For men in the target range, the immediate move is to raise the update with their own doctor and settle what it means personally.
Medical guidance rarely arrives as a single bright line, and this update from the American Cancer Society is one more step in a long human effort to decide when to look for a quiet disease before it speaks. The Society now advises men between 50 and 69 to be screened every two years, a rhythm offered to the public through a CBS segment in which a Columbia urologist, Dr. Christopher Anderson, was asked to explain what it means in practice. The reporting itself is spare, offering the headline and the guest but not the full text, so the deeper reasons and the change from earlier advice remain for the guideline to reveal. For men in that age window, the update gives a defined place to begin a conversation with their own physician.
The American Cancer Society has changed what it tells men about prostate cancer screening. According to a CBS News segment, men between 50 and 69 should now be screened every two years. The segment aired on "The Daily Report," where Dr. Christopher Anderson, a urologist and prostate cancer expert at NewYork-Presbyterian/Columbia University Irving Medical Center, was asked to walk viewers through what the revised guidance says and what it means for them.
The available material is thin. The CBS page offers a short description, not a transcript. It confirms the update, names the guest, and states the age range and interval, but it does not quote Anderson or reproduce the guideline. It does not say what the Society previously advised, which test the interval applies to, or what happens for men outside the 50 to 69 range.
What is clear is that the Society has placed a specific age window and rhythm at the center of its message. For a disease where screening has long meant weighing benefits against drawbacks, a defined interval gives patients and doctors a starting point. The next step is the full guideline, and in the meantime, men in this range can ask their own doctor how the update applies to them.
The American Cancer Society has changed what it tells men about prostate cancer screening. According to the headline on a CBS News video segment, men between the ages of 50 and 69 should now be screened every two years.
The segment aired on "The Daily Report," where Dr. Christopher Anderson was brought on to explain the update. Anderson is a urologist and prostate cancer expert at NewYork-Presbyterian/Columbia University Irving Medical Center. His role in the piece is that of interpreter: he is there to walk viewers through what the revised guidance says and what it means for them.
The material available for this story is thin, and it is worth being plain about that. The CBS page carries a short description of the segment, not a transcript. It confirms that the Society has updated its guidance, names the guest, and gives the age range and the two-year interval in its title. It does not quote Anderson, and it does not reproduce the text of the guideline.
That leaves several questions unanswered by this source. It does not say what the Society previously advised, so the size of the change cannot be measured from here. It does not say which test the new interval applies to, though the keywords attached to the piece point to PSA testing, the blood test commonly used in prostate screening. It also does not say what the guidance recommends for men younger than 50 or older than 69, or whether risk factors alter the schedule.
What can be said is narrow but concrete. The organization has put a specific window, ages 50 to 69, and a specific rhythm, every two years, at the center of its message to men. For a disease where screening decisions have long involved weighing benefits against drawbacks, a clear interval gives patients and doctors a defined starting point for the conversation.
For anyone wanting more than the headline, the next step is the guideline itself. Readers should look for the Society's full published text, and for how the two-year interval compares with its earlier recommendations. Until then, the practical move for men in this age range is to ask their own doctor how the update applies to them.
Citas Notables
Men aged 50 to 69 should get screened for prostate cancer every two years.— American Cancer Society guidance, as stated in CBS News headline